Brassica rapa subsp. narinosa (Tat Soi)

Tat soi (Brassica rapa subsp. narinosa) is a leafy cruciferous vegetable that contains glucosinolates such as glucobrassicanapin and 4-methoxyglucobrassicin, which are enzymatically converted to bioactive isothiocyanates upon chewing or processing. These isothiocyanates drive its antimicrobial and potential chemoprotective effects through modulation of detoxification enzyme pathways.

Origin & History

Brassica rapa subsp. narinosa, commonly known as tatsoi or Chinese flat cabbage, is an Asian subspecies of Brassica rapa cultivated primarily in China for its edible dark green, spoon-shaped leaves that form a rosette. This nutrient-dense cruciferous vegetable is grown worldwide and consumed fresh, cooked, or in salads and soups as a whole food rather than an extracted supplement.

Historical & Cultural Context

Tatsoi has been cultivated especially in China as 'Chinese flat cabbage' or 'tah tsai,' primarily as a food crop rather than in formal traditional medicine systems. No specific historical medicinal uses or traditional medicine applications are documented in the available sources.

Health Benefits

• Antimicrobial properties: In vitro studies showed activity against Bacillus cereus (11.5-12mm inhibition zone) and multidrug-resistant Pseudomonas aeruginosa (evidence quality: preliminary)
• Rich in glucosinolates: Contains glucobrassicanapin, 4-methoxyglucobrassicin, neoglucobrassicin, and other glucosinolates common to cruciferous vegetables (evidence quality: preliminary)
• High phenolic content: Contains elevated levels of p-coumaric acid, kaempferol, and ferulic acid compared to related cultivars (evidence quality: preliminary)
• Carotenoid source: Contains β-carotene, 9Z-β-carotene, and lutein as identified through metabolite profiling (evidence quality: preliminary)
• Primary metabolite content: Rich in glucose, aspartic acid, and glutamic acid based on metabolomic analysis (evidence quality: preliminary)

How It Works

Upon cell disruption, the enzyme myrosinase hydrolyzes tat soi's glucosinolates—including glucobrassicanapin and neoglucobrassicin—into isothiocyanates and indole compounds. These metabolites activate the Nrf2/ARE (antioxidant response element) pathway, upregulating phase II detoxification enzymes such as glutathione S-transferase and quinone reductase. Additionally, 4-methoxyglucobrassicin-derived indole-3-carbinol metabolites may modulate estrogen receptor signaling and cytochrome P450 enzyme activity, particularly CYP1A1 and CYP1B1.

Scientific Research

No human clinical trials, randomized controlled trials, or meta-analyses specifically on Brassica rapa subsp. narinosa (tatsoi) were identified in the available research. Current evidence is limited to in vitro metabolite profiling studies and antimicrobial assays, with no PubMed PMIDs for human intervention studies available.

Clinical Summary

Current evidence for tat soi is limited to in vitro studies; no human clinical trials have been conducted specifically on this subspecies. In vitro antimicrobial testing demonstrated inhibition zones of 11.5–12mm against Bacillus cereus and activity against multidrug-resistant Pseudomonas aeruginosa, classifying it as preliminary evidence only. Broader research on related Brassica rapa subspecies and their glucosinolate profiles in rodent models suggests anti-inflammatory and antiproliferative potential, but direct extrapolation to tat soi requires caution. The overall evidence quality is preclinical, and efficacy in humans has not been established.

Nutritional Profile

Tatsoi (Brassica rapa subsp. narinosa) is a nutrient-dense leafy green with the following approximate profile per 100g fresh weight: Macronutrients: calories ~17-20 kcal, carbohydrates ~2.2g, protein ~1.5-2.0g, fat ~0.2g, dietary fiber ~1.5-2.0g. Micronutrients: Vitamin C approximately 45-60mg (50-67% DV), Vitamin K1 approximately 108-250µg (notably high, bioavailability enhanced by dietary fat co-consumption), Vitamin A (as beta-carotene) approximately 300-400µg RAE, folate approximately 60-80µg DFE, calcium approximately 105-135mg (bioavailability moderately reduced by oxalates, ~40-50% absorption rate), potassium approximately 250-300mg, magnesium approximately 18-22mg, iron approximately 0.9-1.4mg (non-heme, enhanced by co-consumed Vitamin C). Bioactive compounds: glucosinolates total approximately 15-30µmol/g dry weight including glucobrassicanapin, 4-methoxyglucobrassicin, and neoglucobrassicin; hydrolysis yields isothiocyanates and indoles upon cell disruption (chewing, chopping). Total phenolics approximately 200-400mg GAE/100g fresh weight including hydroxycinnamic acids (sinapic acid, caffeic acid derivatives) and flavonoids (quercetin, kaempferol glycosides). Chlorophyll content notable at approximately 50-100mg/100g. Carotenoids include lutein and zeaxanthin (~2-4mg/100g), relevant to ocular health. Bioavailability note: light cooking (blanching <2 min) preserves glucosinolate content better than boiling; fat-soluble vitamins (K, A, carotenoids) require dietary fat for optimal absorption; myrosinase enzyme activity responsible for glucosinolate hydrolysis is partially inactivated by cooking but gut microbiota can partially compensate.

Preparation & Dosage

No clinically studied dosage ranges are available as no human trials exist. Tatsoi is consumed as a whole food vegetable without standardization, typically eaten fresh in salads or cooked in soups and stir-fries. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Bok choy, Chinese cabbage, kale, broccoli, spinach

Safety & Interactions

Tat soi is generally recognized as safe when consumed as a food at typical culinary amounts, with no documented serious adverse effects in healthy adults. High intake of glucosinolate-rich brassicas may suppress thyroid function by interfering with iodine uptake, making it a potential concern for individuals with hypothyroidism or those on thyroid medications such as levothyroxine. Indole compounds derived from its glucosinolates can induce cytochrome P450 enzymes (CYP1A2, CYP3A4), theoretically altering the metabolism of drugs including warfarin, cyclosporine, and certain chemotherapy agents. Safety data during pregnancy and lactation is insufficient; consumption at normal food quantities is likely safe, but high-dose supplemental forms should be avoided until further research is available.